Takeda Pharmaceutical Company Limited Weighted Average Shares
Takeda Pharmaceutical Company Limited (TAK) reported Weighted Average Shares of 1.58 billion shares for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageShares · last filed 2025-06-25
| Period end | Weighted Average Shares 12 month |
|---|---|
| 2025-03-31 | 1.58B shares 20-F · filed 2025-06-25 |
| 2024-03-31 | 1.56B shares 20-F · filed 2025-06-25 |
| 2023-03-31 | 1.55B shares 20-F · filed 2025-06-25 |
| 2022-03-31 | 1.56B shares 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.56B shares 20-F · filed 2023-06-28 |
| 2020-03-31 | 1.56B shares 20-F · filed 2022-06-29 |
| 2019-03-31 | 961.48M shares 20-F · filed 2021-06-29 |
| 2018-03-31 | 780.81M shares 20-F · filed 2020-06-24 |
| 2017-03-31 | 781.10M shares 20-F · filed 2019-06-27 |